Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
Top Cited Papers
- 1 August 2012
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 11 (8), 697-707
- https://doi.org/10.1016/s1474-4422(12)70152-7
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Predictors of Survival in Patients With Parkinson DiseaseArchives of Neurology, 2012
- Genetic influences on cognitive decline in Parkinson's diseaseMovement Disorders, 2012
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesMovement Disorders, 2012
- Neurodegeneration Across Stages of Cognitive Decline in Parkinson DiseaseArchives of Neurology, 2011
- Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: A population‐based studyAnnals of Neurology, 2011
- MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCIMovement Disorders, 2011
- Plasma epidermal growth factor levels predict cognitive decline in Parkinson diseaseAnnals of Neurology, 2010
- CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentMovement Disorders, 2010
- Association between cognition and function in patients with Parkinson disease with and without dementiaMovement Disorders, 2010
- Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementiaMovement Disorders, 2010